<DOC>
	<DOCNO>NCT00060515</DOCNO>
	<brief_summary>The objective study determine safety tolerability RG2133 patient Mitochondrial Disease .</brief_summary>
	<brief_title>RG2133 ( 2',3',5'-Tri-O-Acetyluridine ) Mitochondrial Disease</brief_title>
	<detailed_description />
	<mesh_term>Mitochondrial Diseases</mesh_term>
	<criteria>Mitochondrial Disease</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2005</verification_date>
</DOC>